These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 11232737)

  • 21. Pharmacologic management of the older patient with type 2 diabetes mellitus.
    Neumiller JJ; Setter SM
    Am J Geriatr Pharmacother; 2009 Dec; 7(6):324-42. PubMed ID: 20129254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of current therapeutic interventions on insulin resistance.
    Kobayashi M
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S32-40. PubMed ID: 11220286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin therapy in type 2 diabetes: what is the evidence?
    van Avendonk MJ; Rutten GE
    Diabetes Obes Metab; 2009 May; 11(5):415-32. PubMed ID: 19175375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility and outcomes of insulin therapy in elderly patients with diabetes mellitus.
    Saudek CD; Hill Golden S
    Drugs Aging; 1999 May; 14(5):375-85. PubMed ID: 10408737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies for insulin therapy in type 2 diabetes.
    Edelman SV; Morello CM
    South Med J; 2005 Mar; 98(3):363-71. PubMed ID: 15813164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of sulphonylureas in the management of type 2 diabetes mellitus.
    Rendell M
    Drugs; 2004; 64(12):1339-58. PubMed ID: 15200348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Troglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Plosker GL; Faulds D
    Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
    Machoy M
    Ann Acad Med Stetin; 2004; 50(2):29-39. PubMed ID: 16529163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does rapid transition to insulin therapy in subjects with newly diagnosed type 2 diabetes mellitus benefit glycaemic control and diabetes-related complications? A German population-based study.
    Simons WR; Vinod HD; Gerber RA; Bolinder B
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):520-6. PubMed ID: 17115350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lights and shades in the application of new guidelines for the management of type 2 diabetes mellitus. Practical advice about combined therapy and insulin therapy].
    Sánchez Sánchez O; Sabán Ruiz J
    Med Clin (Barc); 2008 Feb; 130(5):188-96. PubMed ID: 18341835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reappraisal of the pharmacologic approach to treatment of type 2 diabetes mellitus.
    Weissman P
    Am J Cardiol; 2002 Sep; 90(5A):42G-50G. PubMed ID: 12231078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Problems and pitfalls of sulphonylurea therapy in older patients.
    Robertson DA; Home PD
    Drugs Aging; 1993; 3(6):510-24. PubMed ID: 8312676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel drug delivery systems for insulin: clinical potential for use in the elderly.
    Belmin J; Valensi P
    Drugs Aging; 2003; 20(4):303-12. PubMed ID: 12641486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving glycaemic control with current therapies.
    Birkeland KI
    Diabet Med; 1998; 15 Suppl 4():S13-9. PubMed ID: 9868986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of diabetes mellitus in older individuals.
    Morley JE; Perry HM
    Drugs; 1991 Apr; 41(4):548-65. PubMed ID: 1711959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.
    Melander A; Bitzén PO; Faber O; Groop L
    Drugs; 1989 Jan; 37(1):58-72. PubMed ID: 2651086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality improvement project for improving inpatient glycaemic control in non-critically ill patients admitted on medical floor with type 2 diabetes mellitus.
    Khan AA; Shahzad A; Rose S; Al Mohanadi DHSH; Zahid M
    BMJ Open Qual; 2020 Aug; 9(3):. PubMed ID: 32792342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug therapy of non-insulin-dependent diabetes mellitus in the elderly.
    Mooradian AD
    Drugs; 1996 Jun; 51(6):931-41. PubMed ID: 8736615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention.
    Chelliah A; Burge MR
    Drugs Aging; 2004; 21(8):511-30. PubMed ID: 15182216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.